Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Aldrich Richard
Relationship:   Director
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   10    
Direct Shares   444,838    

Indirect Shares

   12,959,539      
Direct Value   $1,394,222    

Indirect Value

   $84,759,662      
Total Shares   13,404,377      
Total Value   $86,153,884      


Altus Pharmaceuticals Inc. $0 Verastem, Inc. $1,387,683 Tempest Therapeutics, Inc $6,539 Altus Pharmaceuticals Inc. $0 Verastem, Inc. $1,387,683 Tempest Therapeutics, Inc $6,539
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   81.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Altus Pharmaceuticals Inc. ALTUQ Director 2006-01-25 30,527 0    Premium*  
            Lipid Sciences Inc LIPD 10% Owner 2006-12-21 0 2006-12-21 3,662,662    Premium*  
            Sequenom Inc SQNM 10% Owner 2008-06-06 0 2008-06-25 5,853,697    Premium*  
            Aradigm Corp ARDM 10% Owner 2008-10-29 0 2008-10-29 1,081,410    Premium*  
            Biospecifics Technologies Corp BSTC 10% Owner 2008-10-30 0 2008-11-14 697,309    Premium*  
            Verastem, Inc. VSTM Director 2014-05-20 408,142 2014-05-20 299,294    Premium*  
            Tempest Therapeutics, Inc TPST Director 2018-12-07 6,169 2018-12-07 130,683    Premium*  
            PTC Therapeutics, Inc. PTCT Director 2015-06-08 0 2013-06-25 300,000    Premium*  
            Concert Pharmaceuticals, Inc. CNCE Director 2023-03-06 0 2023-03-06 0    Premium*  
            Kalvista Pharmaceuticals Inc KALV Director 2016-11-21 0 2017-10-12 934,484    Premium*  
* Premium Members only  

Records found :    141         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
TPST Tempest Therapeutics, Inc Director   –       •      –    2016-05-18 4 B $7.86 $157,200 I/I 20,000 537,056 2.1 -
TPST Tempest Therapeutics, Inc Director   –       •      –    2016-06-01 4 B $7.00 $2,975,000 I/I 425,000 962,056 2.1 -
TPST Tempest Therapeutics, Inc Director   –       •      –    2016-09-30 4 A $0.00 $0 D/D 1,483 607,707 0 -
KALV Kalvista Pharmaceuticals ... Director   –       •      –    2016-11-21 4 A $0.00 $0 I/I 369,419 369,419 0 -
TPST Tempest Therapeutics, Inc Director   –       •      –    2016-12-07 4 GD $0.00 $0 I/I 200,000 0 0 -
TPST Tempest Therapeutics, Inc Director   –       •      –    2016-12-07 4 GA $0.00 $0 D/D 200,000 807,707 0 -
TPST Tempest Therapeutics, Inc Director   –       •      –    2016-12-13 4 GD $0.00 $0 D/D 645,842 161,865 0 -
TPST Tempest Therapeutics, Inc Director   –       •      –    2016-12-13 4 GA $0.00 $0 I/I 645,842 668,192 0 -
TPST Tempest Therapeutics, Inc Director   –       •      –    2016-12-22 4 GD $0.00 $0 D/D 154,519 7,346 0 -
TPST Tempest Therapeutics, Inc Director   –       •      –    2016-12-22 4 GA $0.00 $0 I/I 154,519 330,000 0 -
TPST Tempest Therapeutics, Inc Director   –       •      –    2016-12-30 4 A $1.53 $10,624 D/D 6,944 14,290 0 -
TPST Tempest Therapeutics, Inc Director   –       •      –    2017-03-31 4 A $0.00 $0 D/D 5,681 19,971 0 -
TPST Tempest Therapeutics, Inc Director   –       •      –    2017-06-30 4 A $0.00 $0 D/D 6,810 26,781 0 -
TPST Tempest Therapeutics, Inc Director   –       •      –    2017-09-29 4 A $0.00 $0 D/D 7,482 34,263 0 -
KALV Kalvista Pharmaceuticals ... Director   –       •      –    2017-10-12 4 B $8.61 $4,866,961 I/I 565,065 934,484 2.1 -
TPST Tempest Therapeutics, Inc Director   –       •      –    2017-12-29 4 A $0.00 $0 D/D 7,589 41,852 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2018-01-16 4 OE $2.88 $77,405 D/D 21,236 308,211 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2018-01-16 4 AS $19.08 $405,183 D/D (21,236) 286,975 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2018-01-16 4 AS $19.26 $192,650 I/I (10,000) 77,405 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2018-01-17 4 AS $18.95 $189,900 I/I (10,000) 72,405 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2018-01-18 4 AS $19.36 $193,950 I/I (10,000) 67,405 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2018-01-19 4 AS $19.65 $196,550 I/I (10,000) 62,405 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2018-01-22 4 AS $19.54 $195,450 I/I (10,000) 57,405 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2018-01-23 4 AS $19.67 $196,750 I/I (10,000) 52,405 0 -
CNCE Concert Pharmaceuticals, ... Director   –       •      –    2018-01-24 4 AS $19.83 $198,300 I/I (10,000) 47,405 0 -
  141  Records found
  1   2   3   4   5  6      
  Page 5 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us